Asbury Automotive Group (ABG) Stock Value Rose While Eminence Capital LP Boosted Position by $2.74 Million; Therapeuticsmd (TXMD) Stock Value Declined While Alyeska Investment Group LP Cut Stake

May 18, 2018 - By reb123z

TherapeuticsMD, Inc. (NASDAQ:TXMD) Logo

Anand Parekh decreased its stake in Therapeuticsmd Inc (TXMD) by 56.54% based on its latest 2017Q4 regulatory filing with the SEC. Alyeska Investment Group Lp sold 300,587 shares as the company’s stock declined 18.84% with the market. The hedge fund run by Anand Parekh held 231,023 shares of the health care company at the end of 2017Q4, valued at $1.40 million, down from 531,610 at the end of the previous reported quarter. Alyeska Investment Group Lp who had been investing in Therapeuticsmd Inc for a number of months, seems to be less bullish one the $1.34 billion market cap company. The stock increased 1.64% or $0.1 during the last trading session, reaching $6.2. About 526,621 shares traded. TherapeuticsMD, Inc. (NYSEMKT:TXMD) has declined 30.29% since May 18, 2017 and is downtrending. It has underperformed by 41.84% the S&P500.




Ricky Sandler increased its stake in Asbury Automotive Group Inc (ABG) by 2.28% based on its latest 2017Q4 regulatory filing with the SEC. Eminence Capital Lp bought 43,545 shares as the company’s stock rose 0.39% while stock markets declined. The hedge fund run by Ricky Sandler held 1.95M shares of the automotive aftermarket company at the end of 2017Q4, valued at $124.86 million, up from 1.91M at the end of the previous reported quarter. Eminence Capital Lp who had been investing in Asbury Automotive Group Inc for a number of months, seems to be bullish on the $1.44 billion market cap company. The stock decreased 2.20% or $1.55 during the last trading session, reaching $69.05. About 19,529 shares traded. Asbury Automotive Group, Inc. (NYSE:ABG) has risen 5.55% since May 18, 2017 and is uptrending. It has underperformed by 6.00% the S&P500.

Among 8 analysts covering Asbury Automotive (NYSE:ABG), 3 have Buy rating, 1 Sell and 4 Hold. Therefore 38% are positive. Asbury Automotive had 26 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Asbury Automotive Group, Inc. (NYSE:ABG) earned “Neutral” rating by Bank of America on Wednesday, September 30. Bank of America downgraded Asbury Automotive Group, Inc. (NYSE:ABG) on Wednesday, July 22 to “Underperform” rating. Craig Hallum upgraded Asbury Automotive Group, Inc. (NYSE:ABG) on Tuesday, September 8 to “Buy” rating. The stock has “Buy” rating by Buckingham Research on Tuesday, February 23. The firm has “Hold” rating given on Monday, November 13 by KeyBanc Capital Markets. KeyBanc Capital Markets maintained it with “Buy” rating and $100 target in Friday, August 28 report. The stock of Asbury Automotive Group, Inc. (NYSE:ABG) earned “Hold” rating by KeyBanc Capital Markets on Thursday, August 31. On Tuesday, October 3 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. Jefferies maintained Asbury Automotive Group, Inc. (NYSE:ABG) rating on Friday, June 2. Jefferies has “Hold” rating and $6800 target. The firm has “Sector Weight” rating by KeyBanc Capital Markets given on Wednesday, November 16.

Investors sentiment increased to 1.35 in Q4 2017. Its up 0.44, from 0.91 in 2017Q3. It is positive, as 14 investors sold ABG shares while 49 reduced holdings. 32 funds opened positions while 53 raised stakes. 21.54 million shares or 4.16% more from 20.68 million shares in 2017Q3 were reported. Credit Suisse Ag has invested 0% in Asbury Automotive Group, Inc. (NYSE:ABG). 1832 Asset Limited Partnership invested in 85 shares or 0% of the stock. Texas Permanent School Fund accumulated 0.01% or 12,535 shares. Hbk Invests Lp reported 0% of its portfolio in Asbury Automotive Group, Inc. (NYSE:ABG). Janney Montgomery Scott Limited Liability Co reported 8,699 shares stake. Stone Ridge Asset Management Ltd Liability Co accumulated 6,423 shares or 0.03% of the stock. Trexquant Investment LP holds 0.06% or 7,877 shares. Ingalls Snyder has 0.01% invested in Asbury Automotive Group, Inc. (NYSE:ABG). Ubs Asset Mngmt Americas Incorporated reported 9,013 shares. Koch Inc invested in 5,200 shares. Assetmark stated it has 245 shares. Us Bank & Trust De holds 0% or 814 shares in its portfolio. Swiss Bank & Trust holds 31,700 shares. Parametric Assoc Limited Liability Company has 0.01% invested in Asbury Automotive Group, Inc. (NYSE:ABG) for 100,261 shares. Bluecrest Capital Ltd reported 0.01% stake.

Since February 7, 2018, it had 0 insider buys, and 5 selling transactions for $2.46 million activity. JAMES JUANITA T also sold $66,180 worth of Asbury Automotive Group, Inc. (NYSE:ABG) on Friday, March 2. Another trade for 1,500 shares valued at $103,500 was sold by REDDIN THOMAS. The insider MONAGHAN CRAIG T sold 28,575 shares worth $1.96M. $108,304 worth of Asbury Automotive Group, Inc. (NYSE:ABG) was sold by Stax William Frederick.

Eminence Capital Lp, which manages about $10.55 billion and $6.56B US Long portfolio, decreased its stake in Anthem Inc (NYSE:ANTM) by 298,416 shares to 447,815 shares, valued at $100.76M in 2017Q4, according to the filing. It also reduced its holding in Zynga Inc (NASDAQ:ZNGA) by 122,594 shares in the quarter, leaving it with 35.11M shares, and cut its stake in La Quinta Hldgs Inc (NYSE:LQ).

Another recent and important Asbury Automotive Group, Inc. (NYSE:ABG) news was published by Globenewswire.com which published an article titled: “Market Trends Toward New Normal in Castlight Health, inc, Marriot Vacations Worldwide, AnaptysBio, Compass …” on May 18, 2018.

Analysts await TherapeuticsMD, Inc. (NASDAQ:TXMD) to report earnings on August, 2. They expect $-0.12 EPS, down 20.00% or $0.02 from last year’s $-0.1 per share. After $-0.11 actual EPS reported by TherapeuticsMD, Inc. for the previous quarter, Wall Street now forecasts 9.09% negative EPS growth.

Investors sentiment decreased to 1.62 in 2017 Q4. Its down 0.11, from 1.73 in 2017Q3. It dropped, as 17 investors sold TXMD shares while 25 reduced holdings. 22 funds opened positions while 46 raised stakes. 159.91 million shares or 1.31% less from 162.04 million shares in 2017Q3 were reported. Moreover, First Eagle Invest Mngmt Ltd Liability has 0.02% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD). Blackrock has invested 0% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Moreover, Balyasny Asset Ltd has 0% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD). Fmr Ltd Liability Corporation holds 23.07 million shares. Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD). 59,564 were accumulated by Legal And General Gp Plc. Goldman Sachs Gru Inc stated it has 456,982 shares. Cap Impact Advisors Lc invested in 0.52% or 200,707 shares. Bnp Paribas Arbitrage Sa holds 0% or 35,061 shares. Moreover, 1492 Mgmt Lc has 1.83% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD). The Pennsylvania-based Zeke Capital Advsr Ltd has invested 0.01% in TherapeuticsMD, Inc. (NASDAQ:TXMD). Citadel Advsrs Llc reported 0% stake. Savings Bank Of America De owns 0% invested in TherapeuticsMD, Inc. (NASDAQ:TXMD) for 50,494 shares. Vanguard Group accumulated 11.40M shares or 0% of the stock. Hanson Mcclain Inc invested in 0% or 500 shares.

Another recent and important TherapeuticsMD, Inc. (NASDAQ:TXMD) news was published by Businesswire.com which published an article titled: “TherapeuticsMD Announces Investor and Analyst Day on June 4” on May 16, 2018.

Alyeska Investment Group Lp, which manages about $3.14B and $11.65B US Long portfolio, upped its stake in Zynga Inc (NASDAQ:ZNGA) by 1.51 million shares to 8.61 million shares, valued at $34.46 million in 2017Q4, according to the filing. It also increased its holding in Monster Beverage Corp New by 23,642 shares in the quarter, for a total of 1.20M shares, and has risen its stake in Mohawk Inds Inc (NYSE:MHK).

Among 4 analysts covering TherapeuticsMD (NYSEMKT:TXMD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. TherapeuticsMD had 6 analyst reports since September 21, 2015 according to SRatingsIntel. On Tuesday, December 8 the stock rating was maintained by Stifel Nicolaus with “Buy”. Jefferies maintained TherapeuticsMD, Inc. (NASDAQ:TXMD) on Tuesday, December 8 with “Buy” rating. The rating was reinitiated by Jefferies with “Buy” on Tuesday, November 22. On Monday, September 21 the stock rating was maintained by Jefferies with “Buy”. The stock of TherapeuticsMD, Inc. (NASDAQ:TXMD) earned “Outperform” rating by Oppenheimer on Tuesday, November 22.

TherapeuticsMD, Inc. (NASDAQ:TXMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.